Hematology/Oncology Fellowships

Contact Us

Kelley McInerney
Senior Fellowship Administrator

EMAIL

Dana-Farber Cancer Institute, in collaboration with Mass General Brigham and Boston Children’s Hospital, offers two fellowship programs in hematology/oncology that provide clinical training and basic research training for MDs or MD/PhDs:

  • Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
    • Hematology/Oncology Track
    • Classical Hematology Track
  • Pediatric Hematology/Oncology Training Program

Dana-Farber/Mass General Brigham Fellowship in Adult Hematology/Oncology and Classical Hematology

The Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology prepares academically oriented physicians to become leaders in clinical and laboratory investigation, clinical care, and education.

The program has two interconnected tracks – a Hematology/Oncology Track that admits 14 new fellows each year, and a Classical Hematology Track that admits 2 new fellows each year. After an initial year of intensive clinical training, fellows in both tracks pursue two or more years of in-depth clinical, translational, and/or basic science research.

Hematology/Oncology Fellowship Program

Learn about the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology.

    During the first year of training, fellows in both the Hematology/Oncology Track and the Classical Hematology Track divide their time among the Dana-Farber, Massachusetts General Hospital (MGH), and Brigham and Women's Hospital (BWH) campuses. The combined institutions have more than 1,400 inpatient beds, and provide inpatient and ambulatory hematology and oncology care to patients from around the world.

    Hematology/Oncology Track

    During the clinical year, outpatient hematology and oncology experiences are organized around disease-specific programs, and fellows are supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services provide care and consultative services in hematology and medical oncology to a varied population of patients. Trainees also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. In addition, there are weekly disease-oriented teaching sessions sponsored by the relevant programs.

    Classical Hematology Track

    The goal of the Classical Hematology Track is to prepare physicians for both clinical and research careers in classical hematology. During the clinical year, outpatient malignant and non-malignant hematology experiences will be organized around disease-specific programs, and fellows will be supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services will provide care and consultative services in malignant and non-malignant hematology to a varied population of patients. Trainees will also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. Conferences will include joint conferences with the fellows in the Hematology/Oncology Track and conferences designed specifically for the Classical Hematology fellows.

    In the second year and beyond, fellows in both the Hematology/Oncology Track and the Classical Hematology Track begin a period of immersive research, with the aim of assuming independent research programs in respected academic institutions.

    A variety of investigative opportunities, ranging from the most fundamental molecular biology to clinical trials and health outcome analyses, are available at Dana-Farber, Brigham and Women's Hospital, and MGH, as well as in laboratories located at the MGH Cancer Center in Charlestown, the Harvard Medical School, Boston Children's Hospital, and the Broad Institute of MIT and Harvard. Additional clinical training is available for those in the Hematology/Oncology Track desiring to board in hematology. Additionally, upper-level fellows maintain a longitudinal continuity clinic in the disease center and campus of their choosing.

    All applications for this program are processed through the Electronic Residency Application Service (ERAS). Please note that both tracks are listed under Brigham and Women's Hospital, not Dana-Farber Cancer Institute. Applicants can apply to either one or both tracks.

    The deadline for applications is August 31.

    Erik L. Bao, MD 
    Cincinnati, OH 
    Medical School: Harvard Medical School 
    Residency: University of California, San Francisco

    Winston Becker, MD, PhD
    Advance, North Carolina
    Medical School and PhD: Stanford University
    Residency: Brigham and Women’s Hospital

    Linette Bosques-Nieves, MD, PhD
    Mayagüez, Puerto Rico
    Medical School and PhD: Yale School of Medicine
    Residency: Massachusetts General Hospital

     Ruth E. Choa, MS, MD, PhD
    Ellicott City, Maryland
    Medical School and PhD: University of Pennsylvania
    Residency: Massachusetts General Hospital

     Sienna M. Durbin, MD
    Newton, Massachusetts
    Medical School: Harvard Medical School
    Residency: Massachusetts General Hospital

     Katherine J. Feder, MD, MS
    New York City
    Medical School: University of Michigan
    Residency: Yale New Haven Hospital

     Stacey M. Frumm, MD, PhD
    Wilmette, Illinois
    Medical School and PhD: University of California, San Francisco
    Residency: Brigham and Women’s Hospital

     Andrew D. Knight, MD
    Louisville, Kentucky
    Medical School: University of Cincinnati College of Medicine
    Residency: University of Pittsburgh Medical Center

     David J. Lee, MD, MPH, MMSc
    Los Angeles, CA
    Medical School: Harvard Medical School
    Residency: Massachusetts General Hospital

     Kevin H. Lin, MD, PhD
    Austin, Texas
    Medical School and PhD: Duke University School of Medicine
    Residency: Brigham and Women’s Hospital

     Dylan J. Martini, MD
    Merrimac, Massachusetts
    Medical School: Emory University School of Medicine
    Residency: Massachusetts General Hospital

     Matthew L. Meizlish, MD, PhD
    Weston, Connecticut
    Medical School and PhD: Yale Medical School
    Residency: Massachusetts General Hospital

     Elena M. Michaels, MD
    Oak Park, Illinois
    Medical School: Tufts University School of Medicine
    Residency: University of Chicago

     Ben Ouyang, MD, PhD
    Toronto, Ontario
    Medical School and PhD: University of Toronto
    Residency: Massachusetts General Hospital

     Christof C. Smith, MD, PhD
    Taipei, Taiwan, and Grand Rapids, Michigan
    Medical School and PhD: University of North Carolina School of Medicine
    Residency: Brigham and Women’s Hospital

     Alice Tzeng, MD, PhD
    Lafayette, Louisiana
    Medical School: Cleveland Clinic Lerner College of Medicine
    Residency: Brigham and Women’s Hospital

    Second Year Fellows 2023

    Amin Aalipour, MD, PhD, Fellow DFCI/MGB
    Brandon Aubrey, MBBS, PhD, Fellow DFCI/MGB
    Robert Dilley, MD, PhD, Fellow DFCI/MGB
    Richard Ebright, MD, PhD, Fellow DFCI/MGB
    Jeremy Grevet, MD, PhD, Fellow DFCI/MGB
    Gunsagar Gulati, MD, PhD, Fellow DFCI/MGB
    Joanne I. Hsu, MD, PhD, Fellow DFCI/MGB
    H. Moses Murdock, MD, Fellow DFCI/MGB
    Ashley Odai-Afotey, MD, Fellow DFCI/MGBB
    Tess O’Meara, MD, Fellow DFCI/MGB
    Miriam Osei, MD, MPH, Fellow DFCI/MGB
    Hari S. Raman, MD, MBA, Fellow DFCI/MGB
    David Reshef, MD, PhD, Fellow DFCI/MGB
    Andrew B. Song, MD, Fellow DFCI/MGB
    Sarah Waliany, MD, MS, Fellow DFCI/MGB
    Mike Wang, MD, MHS, Fellow DFCI/MGB

    2022

    Daniel Ardeljan, MD, PhD, Fellow DFCI/MGB
    Narsis Attar, MD, PhD, Fellow DFCI/MGB
    Mary Boulanger, MD, Fellow DFCI/MGB
    Jamie O. Brett, MD, PhD, Fellow DFCI/MGB
    Allison E.B. Chang, MD, PhD, Fellow DFCI/MGB
    Sara J. Char, MD, Fellow DFCI/MGB
    Matthew J. Emmett, MD, PhD, Fellow DFCI/MGB
    Emma C. Fink, MD, PhD, Fellow DFCI/MGB
    Benson M. George, MD, PhD, Fellow DFCI/MGB
    Eran Hodis, MD, PhD, Fellow DFCI/MGB
    Lauren Merz, MSc, MD, Fellow DFCI/MGB
    Ian A. Roundtree, MD, PhD, Fellow DFCI/MGB
    Elliot C. Woods, MD, PhD, Fellow DFCI/MGB

    2021

    Rachel Abelman, MD, Medical Oncologist at Massachusetts General Hospital
    Jordan M. Chinai, MD, PhD, Fellow DFCI/MGB
    Charles S. Dai, MD, Fellow DFCI/MGB
    Elijah P.B. Darnell, MD, Fellow DFCI/MGB
    Haley Ellis, MD, Medical Oncologist at Massachusetts General Hospital
    Dan Y. Gui, MD, PhD, Fellow DFCI/MGB
    Alexander C. Jordan, MD, Fellow DFCI/MGB
    Mwanasha H. Merrill, MD, Medical Oncologist at UCSF Health
    Abirami Natarajan, MD, Medical Oncologist at Duke Health
    Leon Pappas, MSc, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Nolan Priedigkeit, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    John C. Schell, MD, PhD, Fellow DFCI/MGB
    Vinayak Venkataraman, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Jeremiah Wala, MS, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute

    2020

    Justin S. Becker, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Elliott J. Brea, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Elizabeth J. Carstens, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Jooho Chung, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Alissa J. Cooper, MD, Medical Oncologist at Memorial Sloan Kettering Cancer Center
    Brandon M. Huffman, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Nathalie R. Javidi-Sharifi MD, PhD, Fellow DFCI/MGB
    Janice S. Kim, MD, Medical Oncologist at Massachusetts General Hospital
    Marla D. Lipsyc-Sharf, MD, Medical Oncologist at UCLA
    Asaf Maoz, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Richard A. Newcomb, MD, Medical Oncologist at Massachusetts General Hospital
    Erica M. Pimenta, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Thomas J. Roberts, MD, MBA, Medical Oncologist at Massachusetts General Hospital
    Christine E. Ryan, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Maclean S. Sellers, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Rebecca L. Zon, MD, Instructor of Medicine at Dana-Farber Cancer Institute

    2019

    Evan C. Chen, MD, Medical Oncologist at Dana-Farber Cancer Institute
    William J. Gibson, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Julie E. Haydu, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Daniel E. Lage, MD, MBA, MSc, Medical Oncologist at Massachusetts General Hospital
    Jaclyn LoPiccolo, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Alexandra K. Maurer, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Catherine B. Meador, M, PhD, Medical Oncologist at Massachusetts General Hospital
    Arielle J. Medford, MD, Medical Oncologist at Massachusetts General Hospital
    Arnav Mehta, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Vivek Naranbhai, MBCHB, PhD, DPhil, Medical Oncologist at Dana-Farber Cancer Institute
    Philipp J. Rauch, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Aswin Sekar, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Eleni Stavrou, MD, Memorial Sloan Kettering Cancer Center
    Matthew R. Strickland, MD, Medical Oncologist at Massachusetts General Hospital

    2018

    Steven M. Blum, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Cynthia K. Hahn, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Chi-Joan How, MD, Medical Oncologist at Dana-Farber Cancer Institute
    P. Connor Johnson, MD, Instructor in Medicine at Massachusetts General Hospital
    Jonathan M.L. Ostrem, MD, PhD, Assistant Professor UCSF
    Jeffrey W. Patterson-Fortin, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Rishi Puram, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Praful K. Ravi, MBBCh, Medical Oncologist at Dana-Farber Cancer Institute
    Jaime L. Schneider, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Frederick D. Tsai, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Vivek Upadhyay, MD, Vice President of Clinical Development at Nuvalent, and Medical Oncologist at Penn Medicine
    Lachelle D. Weeks, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Kipp A. Weiskopf, MD, PhD, Fellow DF/MGB
    Jordan C. Wengrod, MD, PhD, Director, Oncology Early Clinical Development at Bristol Myers Squibb

    2017

    Daniel L. Abravanel, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Sylvan C. Baca, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Jacob E. Berchuck, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Christopher T. Chen, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Bradley D. Hunter, MD, MPH, Hematology/Oncology Intermountain Medical Group
    Geon Kim, MD, Hematology Attending Massachusetts General Hospital
    Erik K. Knelson, MD, PhD, Clinical Director, Early State Oncology, Merck
    Elizabeth K. Lee, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Mark B. Leick, MD, Medical Oncologist at Massachusetts General Hospital
    Christopher S. Nabel, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Alexander A. Parent, MD, PhD, Medical Director, Oncology TAU, at Takeda Pharmaceuticals
    Christopher R. Reilly, MD, Medical Oncologist at Dana-Farber Cancer Institute
    James A. Torchia, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Mounica Vallurupalli, MD, Instructor in Medicine at Dana-Farber Cancer Institute

    Pediatric Hematology/Oncology Fellowship Program

    The Pediatric Hematology/Oncology Fellowship Program at Dana-Farber Cancer Institute and Boston Children's Hospital is one of the oldest and most distinguished in the world.

    The program admits six new fellows per year. Fellows spend one year in full-time clinical work and two or more years in research training, depending on previous training and interests.

    The program is geared to broadly train MD or MD/PhD fellows in any of the areas of clinical research, including outcomes, ethics, epidemiology, therapeutic trials, and translational research, or in one of the major basic science disciplines: protein chemistry, structural biology, molecular biology, stem cell and developmental biology, genetics, genomics, immunology, systems biology, neuroscience, or cell biology.

    The breadth and diversity of our patient population, combined with the depth of expertise of our teaching faculty, provides the highest quality clinical training in pediatric hematology and oncology. Our program also offers unparalleled opportunities for research and scholarship, fostering the academic passions of all fellows.

    Learn more about the Pediatric Hematology/Oncology Fellowship Program.

    Medical Educator Program for Fellows

    Additionally, fellows accepted into the adult or pediatric fellowship have the option of applying to the Medical Educator Program for Fellows, which runs in tandem with both programs during the second or third year of training.

    Learn more about the Medical Educator Program for Fellows.